ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19

NCT04318418 · clinicaltrials.gov ↗
COMPLETED
Status
3400
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Neuromed IRCCS